The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC
NCT02344979 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2015-01-26
Summary
Purpose: To evaluate the efficacy and safety of rHuTPO/rHuIL-11 in the treatment for chemotherapy-induced thrombocytopenia in patients with NSCLC receiving gemcitabine and cisplatin or carboplatin chemotherapy.
Conditions
Sponsors & Collaborators
-
Shenyang Sunshine Pharmaceutical Co., LTD.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- China
Study Locations
More Related Trials
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients
NCT01238562 ·Status: COMPLETED ·Phase: PHASE1
-
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
NCT00858364 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy
NCT00118638 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy
NCT00117624 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy
NCT01285219 ·Status: COMPLETED ·Phase: PHASE3
-
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479 ·Status: RECRUITING
-
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug
NCT00269997 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
NCT02905916 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
NCT00120679 ·Status: COMPLETED ·Phase: PHASE2
-
Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
NCT01918241 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood
NCT00117442 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies
NCT04773327 ·Status: UNKNOWN ·Phase: NA
-
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2
NCT04345900 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia
NCT03846414 ·Status: UNKNOWN
-
A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
NCT02119715 ·Status: COMPLETED ·Phase: PHASE2
-
Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
NCT00239239 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy
NCT00111137 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
NCT02944604 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
NCT01560195 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study
NCT00115167 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
NCT05301517 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
NCT01637493 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy
NCT00119600 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
NCT02761460 ·Status: UNKNOWN ·Phase: PHASE3
-
PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy
NCT03776604 ·Status: UNKNOWN ·Phase: NA